CybeRelease: (OTC: HSPO) Engages Medco to Distribute Enlyten(TM) Products

(CybeRelease, June 8, 2007) - Lake Harmony, Pa - HealthSport, Inc. (OTC BB: HSPO), a fully integrated developer, manufacturer and marketer of unique and proprietary branded and private label edible film strip nutritional supplements and over-the-counter drugs, announced its wholly owned subsidiary, Enlyten, Inc., has signed a distribution agreement with the Medco Supply Company to distribute its new edible thin-film strip products. Medco is one of the world’s largest suppliers of medical products to athletic trainers, sports medicine professionals, physical therapists and schools.

Under the terms of the agreement, Medco will market Enlyten, Inc.’s edible film strip nutritional supplements, including its new Enlyten SportStrips(TM) (http://enlytenstrips.com) electrolyte thin-film strip products, to professional, collegiate and high school sports teams, sports medicine clinics, athletic trainers, and sports medicine professionals. Medco will develop markets for Enlyten, Inc.’s products through advertising and demonstrations throughout the United States. Enlyten, Inc.’s products will be listed in the August Medco Sports Medicine catalog and are currently displayed at its online homepage, www.medco-athletics.com. Medco will also promote other HealthSport products developed at selected regional and national trade shows.

Enlyten SportStrips exploit the extraordinary delivery capabilities of buccal absorption; a term that simply means delivering active ingredients and compounds into the bloodstream by way of the soft tissue between the cheek and gums. Known scientifically to be an extremely fast and efficient way to deliver drug actives into the bloodstream, buccal absorption of electrolytes bypasses the inherent drawbacks of gastric absorption, an Achilles heel for many athletes who struggle with fatigue, cramping and hydration problems.

“Rarely does a product emerge with the potential to truly alter training and preparation methodologies as well as athletic performance levels in virtually every sports discipline where fatigue and hydration are a win or lose factor. Medco is very excited about the potential of the Enlyten SportStrips technology to have an extraordinary impact on nearly every aspect of sports in such a positive way. We look forward to a very productive year,” stated Don Laux, Medco’s Director of Marketing.

To read the complete release, go to http://biz.yahoo.com/iw/070607/0263327.html

CybeRelease Gainers are Books-A-Million, Inc. (Nasdaq: BAMM), Kimball International, Inc. (Nasdaq: KBALB), Radware Ltd. (Nasdaq: RDWR), Kensey Nash Corporation (Nasdaq: KNSY), PW Eagle Inc. (Nasdaq: PWEI), NeuroMetrix, Inc. (Nasdaq: NURO), NeoMagic Corporation (Nasdaq: NMGC) and Perry Ellis International Inc. (Nasdaq: PERY).

CybeRelease Decliners are Encysive Pharmaceuticals Inc. (Nasdaq: ENCY), PDL BioPharma, Inc. (Nasdaq: PDLI), Neurochem Inc. (Nasdaq: NRMX), ImClone Systems Incorporated (Nasdaq: IMCL), Smith Micro Software, Inc. (Nasdaq: SMSI), Cree, Inc. (Nasdaq: CREE), Comtech Telecommunications Corp. (Nasdaq: CMTL) and James River Coal Company (Nasdaq: JRCC).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail